|
|
Methylphenidate references
American Academy of Child and
Adolescent Psychiatry (2002) Practice parameter for the use of
stimulant medications in the treatment of children, adolescents,
and adults. Journal of the American Academy of
Child & Adolescent Psychiatry , 41,
26S-49S. American Pharmaceutical
Association (2000)New Product Bulliten Concerta
(extended-release methylphenidate HCl). Washington DC:
American Pharmaceutical Association. Arnsten, A. F. (2001)
Dopaminergic and noradrenergic influences on cognitive functions
mediated by prefrontal cortex. In Stimulant Drugs and ADHD
(eds M. V. Solanto, A. F. Arnsten, & F. X. Castellanos), pp.
185-208.
New York: Oxford University Press. Barkley, R. A. (1998)
Behavior rating scales.
In Attention-Deficit/Hyperactivity Disorder: A handbook for
Diagnosis and Treatment, New York: Guilford. Castellanos, F. X., Giedd, J.
N., Elia, J., et al (1997) Controlled stimulant
treatment of ADHD and comorbid Tourette's syndrome: effects of
stimulant and dose. Journal of the American Academy of
Child & Adolescent Psychiatry , 36,
589-596. Chan, Y. P., Swanson, J. M.,
Soldin, S. S., et al (1983) Methylphenidate
hydrochloride given with or before breakfast: II. Effects on plasma
concentration of methylphenidate and ritalinic acid. Pediatrics72, 56-59. Diller, L. H. (1996)The run on
Ritalin. Attention deficit disorder and stimulant treatment in the
1990s. Hastings Center Report, 26,
12-18. Ding, Y. S., Fowler, J. S.,
Volkow, N. D., et al (1994) Pharmacokinetics and in
vivo specificity of [11C] dl-threo-methylphenidate for the
presynaptic dopaminergic neuron. Synapse, 18, 152-160. Douglas, V. I., Barr, R. G.,
Desilets, J., et al (1995) Do high doses of stimulants
impair flexible thinking in attention-deficit hyperactivity
disorder? Journal of the American Academy of
Child & Adolescent Psychiatry, 34,
877-885. DuPaul, G. J. & Barkley,
R. A. (1998) Medication Therapy. In Attention-Deficit Hyperactivity Disorder: A Handbook for
Diagnosis and Treatment (ed. R. A. Barkley), New York:
Guilford Press. Elliott, R., Sahakian, B. J.,
Matthews, K., et al (1997) Effects of methylphenidate
on spatial working memory and planning in healthy young adults.
Psychopharmacology,131,
196-206. Gillberg, C., Melander, H., von
Knorring, A. L., et al (1997) Long-term stimulant
treatment of children with attention-deficit hyperactivity disorder
symptoms. A randomized, double-blind, placebo-controlled trial.
Archives
of General Psychiatry, 54, 857-864. Grace, A. A. (2000)
Psychostimulant actions on dopamine and limbic system function:
relevance to the pathophysiology and treatment of ADHD. In
Stimulant Drugs and ADHD (eds M. V. Solanto, A. F.
Arnsten, & F. X. Castellanos), pp. 134-157. New York: Oxford
University Press. Greenhill, L. L. (2000)
Clinical effects of stimulant medications. In Stimulant Drugs and ADHD (eds M. V. Solanto, A. F.
Arnsten, & F. X. Castellanos), pp. 31-71. New York: Oxford
University Press. Greenhill, L. L., Abikoff, H.
B., Arnold, L. E., et al (1996) Medication treatment
strategies in the MTA Study: relevance to clinicians and
researchers. Journal of the American Academy of
Child & Adolescent Psychiatry, 35,
1304-1313. Greenhill, L. L., Cooper, T.,
Solomon, M., et al (1987) Methylphenidate salivary
levels in children. Psychopharmacological
Bulletin,23, 115-119. Greenhill, L. L., Swanson, J. M.,
Vitiello, B., et al (2001) Impairment and deportment
responses to different methylphenidate doses in children with ADHD:
the MTA titration trial. Journal of the American Academy of
Child & Adolescent Psychiatry, 40,
180-187. Gross-Tsur, V., Manor, O., van
der, M. J., et al (1997) Epilepsy and attention
deficit hyperactivity disorder: is methylphenidate safe and
effective? [republished from Journal of Pediatrics, 130, 40-44].
Journal of Pediatrics, 130,
670-674. Gualtieri, C. T. & Evans,
R. W. (1988) Stimulant treatment for the neurobehavioural
sequelae of traumatic brain injury. Brain Injury, 2, 273-290. Gualtieri, C. T., Hicks,
R. E., Patrick, K., et al (1984) Clinical correlates
of methylphenidate blood levels. Therapeutic Drug
Monitoring, 6, 379-392. Gualtieri, C. T., Kanoy, R.,
Hawk, B., et al (1981) Growth hormone and prolactin
secretion in adults and hyperactive children: relation to
methylphenidate serum levels.
Psychoneuroendocrinology, 6,
331-339. Gualtieri, C. T., Wargin,
W., Kanoy, R., et al (1982b) Clinical studies
of methylphenidate serum levels in children and adults.
Journal of the American Academy of
Child Psychiatry, 21, 19-26. Gualtieri, et al
(1982a) Clinical studies of methylphenidate serum
levels in children and adults. Journal of the American Academy of
Child Psychiatry, 21, 19-26. Higgins, E. S. (1999)
A comparative analysis of antidepressants and stimulants for the
treatment of adults with attention-deficit hyperactivity disorder.
Journal of Family Practice, 48,
15-20. Hill, P. & Taylor, E.
(2001) An auditable protocol for treating attention
deficit/hyperactivity disorder. Archives of Disease in Childhood, 84,
404-409. Hornyak, J. E., Nelson, V.
S., & Hurvitz, E. A. (1997) The use of methylphenidate in
paediatric traumatic brain injury. Pediatric Rehabilitation, 1,
15-17. Hungund, B. L., Perel, J. M., Hurwic,
M. J., et al (1979) Pharmacokinetics of
methylphenidate in hyperkinetic children. British
Journal of Clinical Pharmacology, 8,
571-576. Jadad, A. R., Boyle, M.,
Cunningham, C., et al (2000) Treatment of
attention-deficit/hyperactivity disorder. Evidence Report:
Technology Assessment (Summary) i-viii. Kimko, H. C., Cross, J. T.,
& Abernethy, D. R. (1999) Pharmacokinetics and clinical
effectiveness of methylphenidate. Clinical Pharmacokinetics, 37,
457-470. Loney, J. & Milich, R.
(1982) Hyperactivity, inattention, and aggression in clinical
practice. In Advances in Developmental and Behavioural
Pediatrics, vol. 3 (eds K. Gadow & I. Bailer). Greenwich,
CT: JAI Press. Lord, J. & Paisley, S.
(2000) , The clinical effectiveness and cost-effectiveness of
methylphenidate for hyperactivity in childhood, National Institute for Clinical
Excellence, London, 13. Masand, P. S. & Tesar, G.
E. (1996) Use of stimulants in the medically ill.
Psychiatric Clinic of North America, 19,
515-547. Miller, A., Lee, S., Raina, P.,
et al (1998) A review of therapies for attention
deficit/hyperactivity disorder, Canadian Coordinating Office for
Health Technology Assessment (CCOHTA), Ottawa. MTA Cooperative Group
(1999) A 14-month randomized clinical trial of treatment
strategies for attention-deficit/hyperactivity disorder. The MTA
Cooperative Group. Multimodal Treatment Study of Children with
ADHD. Archives
of General Psychiatry, 56,
1073-1086. Nierenberg, A. A.,
Dougherty, D., & Rosenbaum, J. F. (1998) Dopaminergic
agents and stimulants as antidepressant augmentation strategies.
Journal of Clinical
Psychiatry, 59, Suppl 5, 60-63. Pelham, W. E., Gnagy, E. M.,
Burrows-Maclean, L., et al (2001) Once-a-day Concerta
methylphenidate versus three-times-daily methylphenidate in
laboratory and natural settings. Pediatrics, 107, E105. Pelham, W. E., Greenslade, K. E.,
Vodde-Hamilton, M., et al (1990) Relative efficacy of
long-acting stimulants on children with attention
deficit-hyperactivity disorder: a comparison of standard
methylphenidate, sustained-release methylphenidate,
sustained-release dextroamphetamine, and pemoline. Pediatrics, 86, 226-237. Pelham, W. E., Jr., Sturges, J.,
Hoza, J., et al (1987) Sustained release and standard
methylphenidate effects on cognitive and social behavior in
children with attention deficit disorder. Pediatrics, 80, 491-501. Pentikis, H. S., Simmons, R. D.,
Benedict, M. F., et al (2002) Methylphenidate
bioavailability in adults when an extended-release multiparticulate
formulation is administered sprinkled on food or as an intact
capsule. Journal of the American Academy of
Child & Adolescent Psychiatry, 41,
443-449. Pliszka, S. R., Greenhill,
L. L., Crismon, M. L., et al (2000a) The Texas
Children's Medication Algorithm Project: Report of the Texas
Consensus Conference Panel on Medication Treatment of Childhood
Attention-Deficit Hyperactivity Disorder. Part I. Attention-Deficit
Hyperactivity Disorder. Journal of the American Academy of
Child & Adolescent Psychiatry, 39,
908-919. Pliszka, et al
(2000b) The Texas Children's Medication Algorithm Project:
Report of the Texas Consensus Conference Panel on Medication
Treatment of Childhood Attention-Deficit/Hyperactivity Disorder.
Part II: Tactics. Attention-Deficit/Hyperactivity Disorder.
Journal of the American Academy of
Child & Adolescent Psychiatry, 39,
920-927. Rapoport, J. L., Buchsbaum, M.
S., & Weingartner, H. (1980) Dextroamphetamine: cognitive
and behavioral effects in normal and hyperactive boys and normal
adult males. Psychopharmacological Bulletin, 16,
21-23. Safer, D. J. & Allen, R. P.
(1989) Absence of tolerance to the behavioral effects of
methylphenidate in hyperactive and inattentive children.
Journal of Pediatrics, 115,
1003-1008. Santosh, P. J. & Taylor,
E. (2000) Stimulant drugs.
European Child & Adolescent Psychiatry, 9
(suppl. 1), I27-I43. Satterfield, J. H.,
Cantwell, D. P., & Satterfield, B. T. (1979) Multimodality
treatment. A one-year follow-up of 84 hyperactive boys.
Archives
of General Psychiatry, 36, 965-974. Satterfield, J. H.,
Satterfield, B. T., & Cantwell, D. P. (1980) Multimodality
treatment. A two-year evaluation of 61 hyperactive boys.
Archives
of General Psychiatry, 37, 915-919. Schachar, R., Taylor, E.,
Wieselberg, M., et al (1987) Changes in family function and
relationships in children who respond to methylphenidate.
Journal of the American Academy of
Child & Adolescent Psychiatry, 26,
728-732. Schachar, R. J., Tannock, R.,
Cunningham, C., et al (1997) Behavioral, situational, and
temporal effects of treatment of ADHD with methylphenidate.
Journal of the American Academy of
Child & Adolescent Psychiatry , 36,
754-763. Scottish Intercollegiate
Guidelines Network (2001)Attention Deficit and Hyperkinetic
Disorders in Children and Young People: A national clinical
guideline. Edinburgh: SIGN,
52. Sokol, M. S., Gray, N. S.,
Goldstein, A., et al (1999) Methylphenidate treatment
for bulimia nervosa associated with a cluster B personality
disorder. International Journal of Eating Disorders,
25, 233-237. Solanto, M. V., Arnsten, A.
F., & Castellanos, F. X. (2000) Stimulant
Drugs and ADHD: Basic and Clinical Neuroscience.
New York: Oxford University Press. Spencer, T., Biederman, J.,
Wilens, T., et al (1996) Pharmacotherapy of attention-deficit
hyperactivity disorder across the life cycle. Journal of the American Academy of
Child and Adolescent Psychiatry, 35,
409-432. Srinivas, N. R., Hubbard, J.
W., Korchinski, E. D., et al (1993) Enantioselective
pharmacokinetics of dl-threo-methylphenidate in humans.
Pharmaceutical Research, 10,
14-21. Swanson, J., Greenhill,
L., & Pelham, W. E. (2000) Initiating Concerta (OROS
methylphenidate HCl) qd in children with
attention-deficit/hyperactivity disorder. Journal of Clinical
Research, 3, 59-76. Swanson, J., Gupta, S.,
Guinta, D., et al (1999) Acute tolerance to
methylphenidate in the treatment of attention deficit hyperactivity
disorder in children. Clinical Pharmacology & Therapeutics,
66, 295-305. Swanson, J. & Volkow, N.
(2001) Pharmacokinetic and Pharmacodynamic Properties of
Methylphenidate in Humans. In Stimulant drugs and ADHD (eds M. V. Solanto, A. F.
Arnsten, & F. X. Castellanos), pp. 259-282. New York: Oxford
University Press. Swanson, J. M., Sandman, C.
A., Deutsch, C., et al (1983) Methylphenidate
hydrochloride given with or before breakfast: I. Behavioral,
cognitive, and electrophysiologic effects. Pediatrics, 72, 49-55. Swanson, J. M., Wigal, S.,
Greenhill, L. L., et al (1998) Analog classroom assessment of
Adderall in children with ADHD. Journal of the American Academy of
Child & Adolescent Psychiatry ,
37, 519-526. Taylor, J. R. & Jentsch, J. D.
(2001) Stimulant effects on striatal and cortical dopamine
systems involved in reward-related behaviour and impulsivity. In
Stimulant drugs and ADHD (eds M. V. Solanto, A. F.
Arnsten, & F. X. Castellanos), pp. 104-133. New York: Oxford
University Press. Wigal, S. B., Gupta, S., Guinta,
D., et al (1998) Reliability and validity of the SKAMP
rating scale in a laboratory school setting. Psychopharmacology Bulletin, 34,
47-53. Wolraich, M. L., Greenhill, L.
L., Pelham, W., et al (2001) Randomized, controlled
trial of oros methylphenidate once a day in children with
attention-deficit hyperactivity disorder. Pediatrics , 108, 883-892.
|
|